Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19

Fil: Rothlin, Rodolfo Pedro. Sociedad Argentina de Farmacología Clínica; Argentina.

Guardado en:
Detalles Bibliográficos
Autores principales: Nicolosi, Liliana, Rothlin, Rodolfo Pedro, Duarte, Mariano, Salgado, Maria Victoria, Ignacio, Fernandez Criado, Vetulli, Héctor, Pelorosso, Facundo Germán
Formato: publishedVersion Artículo
Lenguaje:Inglés
Publicado: 2023
Materias:
Losartán
Telmisartán
Hipertensión
Antihipertensivos
COVID-19
Infecciones por Coronavirus
Acceso en línea:http://repositorio.cedes.org/handle/123456789/4720
Aporte de:
Respositorio Digital CRIS del CEDES - Centro de Estudios de Estado y Sociedad de Centro de Estudios de Estado y Sociedad (CEDES)
id I61-R167-123456789-4720
record_format dspace
spelling I61-R167-123456789-47202023-06-01T20:29:11Z Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19 Nicolosi, Liliana Rothlin, Rodolfo Pedro Duarte, Mariano Salgado, Maria Victoria Ignacio, Fernandez Criado Vetulli, Héctor Pelorosso, Facundo Germán Losartán Telmisartán Hipertensión Antihipertensivos COVID-19 Infecciones por Coronavirus Fil: Rothlin, Rodolfo Pedro. Sociedad Argentina de Farmacología Clínica; Argentina. Fil: Pelorosso, Facundo Germán. Hospital de Alta Complejidad El Calafate SAMIC. Servicio de Anatomía Patológica; Argentina. Fil: Duarte, Mariano. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas "José de San Martín". División de Cardiología. Laboratorio de Hipertensión; Argentina. Fil: Nicolosi, Liliana. Hospital Español de Buenos Aires. División de Cardiología; Argentina. Fil: Fernández Criado, Ignacio. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas "José de San Martín". Sección de Tecnología Educativa e Informática Médica; Argentina. Fil: Salgado, María Victoria. CEDES. Centro de Estudios de Estado y Sociedad. Área de Salud, Economía y Sociedad; Argentina. Fil: Vetulli, Héctor. Sanatorio Otamendi y Miroli. Servicio de Electrofisiología Cardíaca, Arritmias y Marcapasos; Argentina. 2023-05-25T23:54:18Z 2023-05-25T23:54:18Z 2023-04 info:eu-repo/semantics/publishedVersion info:ar-repo/semantics/artículo info:eu-repo/semantics/article Rothlin RP, Pelorosso FG, Duarte M, Nicolosi L, Ignacio FC, Salgado MV, Vetulli H. Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19. Pharmacol Res Perspect. 2023 Apr;11(2):e01083. Disponible en: http://repositorio.cedes.org/handle/123456789/4720. 2052-1707 http://repositorio.cedes.org/handle/123456789/4720 10.1002/prp2.1083 eng info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/4.0/ application/pdf Pharmacol Res Perspect. 2023 Apr;11(2):e01083.
institution Centro de Estudios de Estado y Sociedad (CEDES)
institution_str I-61
repository_str R-167
collection Respositorio Digital CRIS del CEDES - Centro de Estudios de Estado y Sociedad
language Inglés
topic Losartán
Telmisartán
Hipertensión
Antihipertensivos
COVID-19
Infecciones por Coronavirus
spellingShingle Losartán
Telmisartán
Hipertensión
Antihipertensivos
COVID-19
Infecciones por Coronavirus
Nicolosi, Liliana
Rothlin, Rodolfo Pedro
Duarte, Mariano
Salgado, Maria Victoria
Ignacio, Fernandez Criado
Vetulli, Héctor
Pelorosso, Facundo Germán
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
topic_facet Losartán
Telmisartán
Hipertensión
Antihipertensivos
COVID-19
Infecciones por Coronavirus
description Fil: Rothlin, Rodolfo Pedro. Sociedad Argentina de Farmacología Clínica; Argentina.
format publishedVersion
Artículo
Artículo
author Nicolosi, Liliana
Rothlin, Rodolfo Pedro
Duarte, Mariano
Salgado, Maria Victoria
Ignacio, Fernandez Criado
Vetulli, Héctor
Pelorosso, Facundo Germán
author_facet Nicolosi, Liliana
Rothlin, Rodolfo Pedro
Duarte, Mariano
Salgado, Maria Victoria
Ignacio, Fernandez Criado
Vetulli, Héctor
Pelorosso, Facundo Germán
author_sort Nicolosi, Liliana
title Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
title_short Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
title_full Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
title_fullStr Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
title_full_unstemmed Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19
title_sort telmisartan and losartan: the marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with covid-19
publishDate 2023
url http://repositorio.cedes.org/handle/123456789/4720
work_keys_str_mv AT nicolosililiana telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT rothlinrodolfopedro telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT duartemariano telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT salgadomariavictoria telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT ignaciofernandezcriado telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT vetullihector telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
AT pelorossofacundogerman telmisartanandlosartanthemarkeddifferencesbetweentheirchemicalandpharmacologicalpropertiesmayexplainthedifferenceintherapeuticefficacyinhospitalizedpatientswithcovid19
_version_ 1768086981433098240

Ejemplares similares